Change - Announcement of Cessation::Cessation as Alternate Director - Mr. Jeffrey B. Jump

Issuer & Securities

Issuer/ Manager
BIOSENSORS INTERNATIONAL GROUP, LTD.
Securities
BIOSENSORS INT'L GROUP, LTD. - BMG113251000 - B20

Announcement Details

Announcement Title
Change - Announcement of Cessation
Date &Time of Broadcast
24-Jul-2014 17:41:56
Status
New
Announcement Sub Title
Cessation as Alternate Director - Mr. Jeffrey B. Jump
Announcement Reference
SG140724OTHRSR1V
Submitted By (Co./ Ind. Name)
Ronald H. Ede
Designation
CFO/ Company Secretary
Description (Please provide a detailed description of the event in the box below)
Cessation of Mr Jeffrey B. Jump as an Alternate Director to Dr Jack Wang

Additional Details

Name Of Person
Jeffrey B. Jump
Age
55
Is effective date of cessation known?
Yes
If yes, please provide the date
24/07/2014
Detailed Reason (s) for cessation
Mr. Jeffrey B. Jump ceased as an Alternate Director to Dr. Jack Wang upon Dr. Wang's retirement as an Executive Director of the Company at the Annual General Meeting held on 24 July 2014.
Are there any unresolved differences in opinion on material matters between the person and the board of directors, including matters which would have a material impact on the group or its financial reporting?
No
Is there any matter in relation to the cessation that needs to be brought to the attention of the shareholders of the listed issuer?
No
Any other relevant information to be provided to shareholders of the listed issuer?
Yes
If Yes, Please provide full details
Mr. Jump will continue to remain as President of Cardiovascular Business Unit
Date of Appointment to current position
26/07/2012
Does the AC have a minimum of 3 members (taking into account this cessation)?
Yes
Number of Independent Directors currently resident in Singapore (taking into account this cessation)
3
Number of cessations of appointments specified in Listing Rule 704 (7) or Catalist Rule 704 (6) over the past 12 months
3
Job Title (e.g. Lead ID, AC Chairman, AC Member etc.)
President of Cardiovascular Business Unit
Role and responsibilities
Primarily responsible for the Company's cardiovascular business worldwide and oversight for critical care products, spectrum dynamics and peripherals business units.
Familial relationship with any director and/ or substantial shareholder of the listed issuer or of any of its principal subsidiaries
None.
Shareholding interest in the listed issuer and its subsidiaries?
Yes
Shareholding Details
Mr. Jump owns 2,150,000 options in Biosensors and is deemed interested in 2,691,000 shares held by his wife.
Other Directorships
Past (for the last 5 years)
Please see attached
Present
Please see attached

Attachments

Other_Directorships_of_JeffreyJump.pdf
Total size =15K